Trial · NCT02740179
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dizziness | Cardiac disorders | Eplerenone | 4 | 20 | |
| other | Dizziness | Cardiac disorders | Placebo | 0 | 20 | |
| other | Gastrointestinal Symptoms | Gastrointestinal disorders | Eplerenone | 4 | 20 | |
| other | Gastrointestinal Symptoms | Gastrointestinal disorders | Placebo | 3 | 20 | |
| other | Rash | Skin and subcutaneous tissue disorders | Eplerenone | 3 | 20 | |
| other | Rash | Skin and subcutaneous tissue disorders | Placebo | 1 | 20 | |
| other | Upper Respiratory Infection | Respiratory, thoracic and mediastinal disorders | Eplerenone | 3 | 20 | |
| other | Upper Respiratory Infection | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 20 | |
| other | Other Infection | Infections and infestations | Eplerenone | 5 | 20 | |
| other | Other Infection | Infections and infestations | Placebo | 6 | 20 | |
| other | Musculoskeletal Pain | Musculoskeletal and connective tissue disorders | Eplerenone | 3 | 20 | |
| other | Musculoskeletal Pain | Musculoskeletal and connective tissue disorders | Placebo | 4 | 20 | |
| other | Cardiovascular Symptoms | Cardiac disorders | Eplerenone | 2 | 20 | |
| other | Cardiovascular Symptoms | Cardiac disorders | Placebo | 3 | 20 | |
| other | Injuries | Injury, poisoning and procedural complications | Eplerenone | 2 | 20 | |
| other | Injuries | Injury, poisoning and procedural complications | Placebo | 3 | 20 | |
| other | Other Respiratory Symptoms | Respiratory, thoracic and mediastinal disorders | Eplerenone | 1 | 20 | |
| other | Other Respiratory Symptoms | Respiratory, thoracic and mediastinal disorders | Placebo | 2 | 20 | |
| other | Urinary Volume Increase | Renal and urinary disorders | Eplerenone | 2 | 20 | |
| other | Urinary Volume Increase | Renal and urinary disorders | Placebo | 0 | 20 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02740179/events